HUE040419T2 - Analgetikus gyógyászati kompozíció orális beadásra - Google Patents
Analgetikus gyógyászati kompozíció orális beadásraInfo
- Publication number
- HUE040419T2 HUE040419T2 HUE12735347A HUE12735347A HUE040419T2 HU E040419 T2 HUE040419 T2 HU E040419T2 HU E12735347 A HUE12735347 A HU E12735347A HU E12735347 A HUE12735347 A HU E12735347A HU E040419 T2 HUE040419 T2 HU E040419T2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- oral administration
- analgesic pharmaceutical
- analgesic
- oral
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL39506911A PL395069A1 (pl) | 2011-05-31 | 2011-05-31 | Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE040419T2 true HUE040419T2 (hu) | 2019-03-28 |
Family
ID=46513810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE12735347A HUE040419T2 (hu) | 2011-05-31 | 2012-05-31 | Analgetikus gyógyászati kompozíció orális beadásra |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9101577B2 (hu) |
| EP (1) | EP2714042B1 (hu) |
| DK (1) | DK2714042T3 (hu) |
| ES (1) | ES2708689T3 (hu) |
| HU (1) | HUE040419T2 (hu) |
| PL (2) | PL395069A1 (hu) |
| WO (1) | WO2012165985A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014150343A1 (en) * | 2013-03-15 | 2014-09-25 | Russell Jaffe | Soft gel encapsulation |
| GB2607333A (en) * | 2021-06-03 | 2022-12-07 | Horopito Ltd | Pain relief composition |
| EP4389120A1 (en) * | 2022-12-20 | 2024-06-26 | Inflacod Sp. z o.o. | An anti-inflammatory pharmaceutical composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2116257T3 (da) * | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
| AU2002350088A1 (en) * | 2001-06-22 | 2003-01-08 | Millard Marsden Mershon | Compositions and methods for reducing blood and fluid loss from open wounds |
| US7147868B2 (en) * | 2001-08-27 | 2006-12-12 | Kyowa Chemical Industry Co., Ltd. | Antacid and laxative tablets |
| US20040048870A1 (en) * | 2002-09-06 | 2004-03-11 | Amir Ahmad A. | Composition for the prevention and treatment of migraine headaches |
| US20040259899A1 (en) * | 2003-04-08 | 2004-12-23 | Sanghvi Suketu P. | Combination therapy for constipation |
| MXPA06003452A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente. |
| US20080220064A1 (en) * | 2006-12-06 | 2008-09-11 | Ramesh Ketkar Anant | Extended release matrix formulations of morphine |
-
2011
- 2011-05-31 PL PL39506911A patent/PL395069A1/pl unknown
-
2012
- 2012-05-31 US US14/122,712 patent/US9101577B2/en active Active
- 2012-05-31 WO PCT/PL2012/050016 patent/WO2012165985A1/en active Application Filing
- 2012-05-31 ES ES12735347T patent/ES2708689T3/es active Active
- 2012-05-31 PL PL12735347T patent/PL2714042T3/pl unknown
- 2012-05-31 DK DK12735347.2T patent/DK2714042T3/da active
- 2012-05-31 EP EP12735347.2A patent/EP2714042B1/en active Active
- 2012-05-31 HU HUE12735347A patent/HUE040419T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2714042B1 (en) | 2018-08-29 |
| ES2708689T3 (es) | 2019-04-10 |
| PL2714042T3 (pl) | 2019-03-29 |
| US9101577B2 (en) | 2015-08-11 |
| WO2012165985A1 (en) | 2012-12-06 |
| PL395069A1 (pl) | 2012-12-03 |
| US20140127302A1 (en) | 2014-05-08 |
| DK2714042T3 (da) | 2019-01-02 |
| EP2714042A1 (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL228709A0 (en) | Dosage unit form for oral administration | |
| EP2747563A4 (en) | COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS | |
| EP2661273A4 (en) | IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION | |
| EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
| HRP20160989T1 (hr) | Otopina za oralnu primjenu | |
| EP2731605A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION | |
| HK1199821A1 (en) | Oral pharmaceutical composition | |
| ZA201105572B (en) | Pharmaceutical composition for oral administration | |
| HK1199822A1 (zh) | 口服給藥用醫藥組合物 | |
| EP2668852A4 (en) | COMPOSITION FOR ORAL ADMINISTRATION | |
| PL2714042T3 (pl) | Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego | |
| IL227651A (en) | Topical pharmacological formulations containing 220b | |
| EP2851074A4 (en) | ANALGETIC PHARMACEUTICAL COMPOSITION | |
| EP2520300A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| EP2529755A4 (en) | PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION | |
| HUP0900482A2 (en) | Pharmaceutical formulation for oral administration | |
| EP2979698A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| ZA201205978B (en) | Solid pharmaceutical composition for buccal administration of agomelatine |